BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17088983)

  • 1. Identification of ID2 associated with invasion of hepatitis C virus-related hepatocellular carcinoma by gene expression profile.
    Tsunedomi R; Iizuka N; Yamada-Okabe H; Tamesa T; Okada T; Sakamoto K; Takashima M; Hamaguchi T; Miyamoto T; Uchimura S; Hamamoto Y; Yamada M; Oka M
    Int J Oncol; 2006 Dec; 29(6):1445-51. PubMed ID: 17088983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method.
    Iizuka N; Oka M; Yamada-Okabe H; Mori N; Tamesa T; Okada T; Takemoto N; Tangoku A; Hamada K; Nakayama H; Miyamoto T; Uchimura S; Hamamoto Y
    Cancer Res; 2002 Jul; 62(14):3939-44. PubMed ID: 12124323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
    Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-based molecular profiling of hepatitis C virus-related hepatocellular carcinoma.
    Takemoto N; Iizuka N; Yamada-Okabe H; Hamada K; Tamesa T; Okada T; Hashimoto K; Sakamoto K; Takashima M; Miyamoto T; Uchimura S; Hamamoto Y; Oka M
    Int J Oncol; 2005 Mar; 26(3):673-8. PubMed ID: 15703822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased ID2 promotes metastatic potentials of hepatocellular carcinoma by altering secretion of vascular endothelial growth factor.
    Tsunedomi R; Iizuka N; Tamesa T; Sakamoto K; Hamaguchi T; Somura H; Yamada M; Oka M
    Clin Cancer Res; 2008 Feb; 14(4):1025-31. PubMed ID: 18281534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of genes preferentially methylated in hepatitis C virus-related hepatocellular carcinoma.
    Deng YB; Nagae G; Midorikawa Y; Yagi K; Tsutsumi S; Yamamoto S; Hasegawa K; Kokudo N; Aburatani H; Kaneda A
    Cancer Sci; 2010 Jun; 101(6):1501-10. PubMed ID: 20345479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray.
    Iizuka N; Oka M; Yamada-Okabe H; Hamada K; Nakayama H; Mori N; Tamesa T; Okada T; Takemoto N; Matoba K; Takashima M; Sakamoto K; Tangoku A; Miyamoto T; Uchimura S; Hamamoto Y
    Int J Oncol; 2004 Mar; 24(3):565-74. PubMed ID: 14767541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
    Mas VR; Maluf DG; Stravitz R; Dumur CI; Clark B; Rodgers C; Ferreira-Gonzalez A; Fisher RA
    Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of expression of cytochrome P450 genes in progression of hepatitis C virus-associated hepatocellular carcinoma.
    Tsunedomi R; Iizuka N; Hamamoto Y; Uchimura S; Miyamoto T; Tamesa T; Okada T; Takemoto N; Takashima M; Sakamoto K; Hamada K; Yamada-Okabe H; Oka M
    Int J Oncol; 2005 Sep; 27(3):661-7. PubMed ID: 16077914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
    Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
    Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
    Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M
    Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of differentially expressed genes in hepatocellular carcinoma with hepatitis C virus by suppression subtractive hybridization.
    Kotaka M; Chen GG; Lai PB; Lau WY; Chan PK; Leung TW; Li AK
    Oncol Res; 2002; 13(3):161-7. PubMed ID: 12549625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virus-associated hepatocellular carcinoma.
    Iizuka N; Sakaida I; Moribe T; Fujita N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Uchida K; Terai S; Sakamoto K; Tamesa T; Oka M
    Anticancer Res; 2006; 26(6C):4713-9. PubMed ID: 17214331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
    Damdinsuren B; Nagano H; Kondo M; Yamamoto H; Hiraoka N; Yamamoto T; Marubashi S; Miyamoto A; Umeshita K; Dono K; Nakamori S; Wakasa K; Sakon M; Monden M
    Int J Oncol; 2005 Feb; 26(2):319-27. PubMed ID: 15645115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible contribution to hepatocarcinogenesis of X transcript of hepatitis B virus in Japanese patients with hepatitis C virus.
    Tamori A; Nishiguchi S; Kubo S; Koh N; Moriyama Y; Fujimoto S; Takeda T; Shiomi S; Hirohashi K; Kinoshita H; Otani S; Kuroki T
    Hepatology; 1999 May; 29(5):1429-34. PubMed ID: 10216126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
    Kurokawa Y; Honma K; Takemasa I; Nakamori S; Kita-Matsuo H; Motoori M; Nagano H; Dono K; Ochiya T; Monden M; Kato K
    Int J Oncol; 2006 Feb; 28(2):383-91. PubMed ID: 16391793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the RD RNA binding protein in hepatitis C virus-related hepatocellular carcinoma.
    Iida M; Iizuka N; Tsunedomi R; Tsutsui M; Yoshida S; Maeda Y; Tokuhisa Y; Sakamoto K; Yoshimura K; Tamesa T; Oka M
    Oncol Rep; 2012 Aug; 28(2):728-34. PubMed ID: 22614758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resampling based on geographic patterns of hepatitis virus infection reveals a common gene signature for early intrahepatic recurrence of hepatocellular carcinoma.
    Uchimura S; Iizuka N; Tamesa T; Miyamoto T; Hamamoto Y; Oka M
    Anticancer Res; 2007; 27(5A):3323-30. PubMed ID: 17970077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression profiles of sense and antisense transcripts between HCV-associated hepatocellular carcinoma and corresponding non-cancerous liver tissue.
    Nagai K; Kohno K; Chiba M; Pak S; Murata S; Fukunaga K; Kobayashi A; Yasue H; Ohkohchi N
    Int J Oncol; 2012 Jun; 40(6):1813-20. PubMed ID: 22366890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.